CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Syntekabio Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Syntekabio Inc
18, Gukjegwahak 17-ro, Yuseong-gu
Phone: +82 29600982p:+82 29600982 DAEJEON, 34002  South Korea Ticker: 226330226330

Business Summary
SyntekaBio Inc is a Korea-based company principally engaged in the artificial intelligence (AI) based drug development business. The Company is mainly engaged in the development and provision of big data-based AI technologies, including algorithmic personal genome mapping platform (PMAP) technology. The Company mainly supports new drug development and clinical research through big data analysis. In addition, the Company is mainly engaged in the provision of drug candidate discovery, optimization and other AI-based services.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202512/31/2024Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Co-Chief Executive Officer, Director Jong SeonJung 57
Co-Chief Executive Officer, Director Tae SunKim 45
Chief Financial Officer Ok GuKang 42 1/1/2020 1/1/2020
4 additional Officers and Directors records available in full report.

General Information
Number of Employees: 61 (As of 12/31/2024)
Outstanding Shares: 24,258,475 (As of 11/6/2025)
Shareholders: 23,749
Stock Exchange: KDQ
Fax Number: +82 262800984


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, December 12, 2025